Effient (Prasugrel HCl) Patent Expiration, LOE Window & CMS Spending

Effient (Prasugrel HCl) by Cosette: Off-Patent Genericized (AB Competition), 6 AB generics, $981K 2024 CMS Part D & Medicaid spend, and 4 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorCosette
FDA Application & PathwayN022307 (NDA)
Exclusivity / Cliff HorizonOff-Patent Genericized (AB Competition)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity DateNot listed / N/A
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors6
2024 CMS Total Public Spend$981K
2024 Medicare Part D Spend$903K
2024 Medicaid Spend$78K
Reported Wholesale Price Change (CA SB 17)4 WAC filings (max 32.9% 2-yr change)